Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
555.95B | 562.40B | 540.15B | 456.48B | 389.90B | 374.21B | Gross Profit |
262.70B | 267.44B | 254.89B | 204.46B | 172.81B | 164.17B | EBIT |
78.83B | 83.52B | 78.80B | 44.41B | 30.68B | 31.60B | EBITDA |
97.35B | 102.61B | 111.51B | 64.08B | 48.73B | 49.16B | Net Income Common Stockholders |
48.27B | 52.12B | 61.69B | 38.92B | 21.27B | 19.22B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
173.54B | 188.75B | 139.88B | 121.44B | 117.69B | 102.92B | Total Assets |
708.73B | 718.28B | 672.87B | 618.64B | 555.82B | 519.08B | Total Debt |
24.13B | 34.05B | 32.88B | 57.07B | 54.05B | 54.65B | Net Debt |
-149.41B | -154.70B | -101.55B | -64.36B | -63.64B | -48.27B | Total Liabilities |
229.08B | 242.56B | 228.10B | 231.81B | 215.47B | 204.31B | Stockholders Equity |
468.89B | 467.86B | 436.64B | 379.63B | 333.59B | 308.32B |
Cash Flow | Free Cash Flow | ||||
0.00 | 88.18B | 39.70B | 19.58B | 33.52B | 16.33B | Operating Cash Flow |
0.00 | 99.03B | 63.83B | 40.42B | 51.64B | 32.84B | Investing Cash Flow |
0.00 | -28.64B | 2.65B | -32.94B | -28.33B | -18.62B | Financing Cash Flow |
0.00 | -26.24B | -57.50B | -10.93B | -16.16B | -17.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $964.16B | 18.02 | 11.39% | 1.60% | 4.12% | -14.50% | |
66 Neutral | $4.51B | 12.29 | 5.40% | 3.67% | 4.15% | -12.21% | |
$9.70B | 19.59 | 19.46% | 2.42% | ― | ― | ||
$7.22B | 15.24 | 16.07% | 2.30% | ― | ― | ||
$12.30B | 21.29 | 12.94% | 1.45% | ― | ― | ||
$1.93B | 26.89 | 4.03% | 3.21% | ― | ― | ||
80 Outperform | ¥676.41B | 16.26 | 2.05% | 3.24% | 36.34% |